Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Guida

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
Rheumatology (Oxford, England)|January 13, 2012
PTPN22 R620W polymorphism in the ANCA-associated vasculitidesDavide Martorana, Federica Maritati, Giovanni Malerba, et al.
Biomedicines|September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super RespondersDiego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Journal of Personalized Medicine|June 25, 2026
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter CohortStefania Nicola, Simone Negrini, Fulvia Ribolla, et al.
The World Allergy Organization Journal|October 1, 2020
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the <i>Severe Asthma Network in Italy</i> (<i>SANI</i>)Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2023
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi ConsensusGiorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
The European Respiratory Journal|April 9, 2021
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
Rheumatology (Oxford, England)|January 13, 2012
PTPN22 R620W polymorphism in the ANCA-associated vasculitidesDavide Martorana, Federica Maritati, Giovanni Malerba, et al.
Biomedicines|September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super RespondersDiego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Journal of Personalized Medicine|June 25, 2026
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter CohortStefania Nicola, Simone Negrini, Fulvia Ribolla, et al.
The World Allergy Organization Journal|October 1, 2020
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the <i>Severe Asthma Network in Italy</i> (<i>SANI</i>)Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2023
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi ConsensusGiorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
The European Respiratory Journal|April 9, 2021
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Pageof 8